ITEL has signed an agreement with Advanced Accelerator Applications to manufacture and commercialise F-18 radiopharmaceuticals to hospitals and imaging centers in selected regions of Southern Italy.
Following AIFA authorisation, ITEL will manufacture F-18 radiopharmaceuticals under AAA license in its production plant in Ruvo di Puglia (BA) and commercialise them across the PET centers located in select regions of Southern Italy. AAA’s key F-18 product is Gluscan®, its branded fluorodeoxyglucose (FDG) PET imaging agent which assists in the diagnosis of serious diseases, primarily in oncology, by assessing glucose metabolism.
“AAA is very active in the European F-18 PET market with 13 PET production facilities based in France, Germany, Italy, Poland, Portugal and Spain”, noted Stefano Buono, Chief Executive Officer of AAA. “This agreement will reinforce AAA’s position as one of the leading companies in the F-18 PET market in Italy.”